BioHarvest Sciences Inc is a biotechnology company specializing in the development and commercialization of plant cell-derived bioactives for the natural health, skincare and aesthetic medicine markets. Using its proprietary BioFarming platform, the company cultivates pure plant cells in bioreactors to produce high-potency botanical extracts. These extracts are designed to deliver enhanced antioxidant, anti-inflammatory and regenerative properties without the variability often associated with traditional agriculture.
The company’s product portfolio spans nutraceutical ingredients, topical cosmeceutical formulations and injectable aesthetic compounds. By controlling the entire cultivation process—from cell selection through harvest—BioHarvest Sciences can tailor molecular profiles to meet specific performance benchmarks. Its ingredients are incorporated by contract manufacturers, dermatological clinics and consumer brands seeking clinically validated, sustainable alternatives to conventional botanicals.
Founded in 2013 in Israel and later establishing its corporate headquarters in Hempstead, New York, BioHarvest Sciences has aligned its research and production capabilities across North America, Europe and Asia. The company completed its initial public offering on the Nasdaq in 2021, opening access to U.S. capital markets to accelerate product development and global market entry. Its R&D operations remain centered in Tel Aviv, where ongoing research explores new plant species and applications in wellness and aesthetics.
Leadership at BioHarvest Sciences is headed by Chief Executive Officer David J. McIntosh, whose background spans biotechnology licensing and strategic partnerships. The executive team includes seasoned professionals in pharmaceutical development, consumer product marketing and industrial manufacturing. Guided by an independent board of directors with extensive life-sciences experience, the company continues to expand its pipeline of patented cell-based extracts and forge collaborations across multiple end-markets.
AI Generated. May Contain Errors.
